Lista de obras - Andre-Guy Martin - Dominio Público Uruguay

An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome.

artículo científico publicado en 2008

Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.

artículo científico publicado en 2015

Bypassing the learning curve in permanent seed implants using state-of-the-art technology

artículo científico publicado en 2006

Calcifications in low-dose rate prostate seed brachytherapy treatment: post-planning dosimetry and predictive factors.

artículo científico publicado en 2015

Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models

artículo científico publicado en 2017

Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate Cancer

artículo científico publicado en 2015

Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy?

artículo científico publicado en 2017

Does prostate volume has an impact on biochemical failure in patients with localized prostate cancer treated with HDR boost?

artículo científico publicado en 2016

Dose escalation to the dominant intraprostatic lesion defined by sextant biopsy in a permanent prostate I-125 implant: a prospective comparative toxicity analysis.

artículo científico publicado en 2009

Dosimetric consequences of manual pullback procedure for coronary artery radiotherapy with 90Sr/90Y beta-source

artículo científico publicado en 2004

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial

artículo científico publicado en 2018

External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer

artículo científico publicado en 2017

High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomes

artículo científico publicado en 2017

Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy.

artículo científico publicado en 2016

Image-guided high-dose-rate brachytherapy boost to the dominant intraprostatic lesion using multiparametric magnetic resonance imaging including spectroscopy: Results of a prospective study.

artículo científico publicado en 2016

Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy

scientific article published on 23 November 2016

Multicenter Evaluation of Biochemical Relapse-Free Survival Outcomes for Intraoperatively Planned Prostate Brachytherapy Using an Automated Delivery System.

artículo científico publicado en 2017

Permanent prostate implant using high activity seeds and inverse planning with fast simulated annealing algorithm: A 12-year Canadian experience.

artículo científico publicado en 2006

Postimplant dosimetry using a Monte Carlo dose calculation engine: a new clinical standard

artículo científico publicado en 2007

Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.

artículo científico publicado en 2014

RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients.

artículo científico publicado en 2013

Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer

artículo científico publicado en 2015

Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data.

artículo científico publicado en 2016

The Prostate Cancer Risk Stratification Project: Database Construction and Risk Stratification Outcome Analysis

artículo científico publicado en 2014

The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysis.

artículo científico publicado en 2013

Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian population.

artículo científico publicado en 2017

[Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience]

artículo científico publicado en 2010

[The impact of 3D image guided prostate brachytherapy on therapeutic ratio: the Quebec University Hospital experience]

artículo científico publicado en 2007

Lista de obras de Andre-Guy Martin

An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome.

Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.

Bypassing the learning curve in permanent seed implants using state-of-the-art technology

Calcifications in low-dose rate prostate seed brachytherapy treatment: post-planning dosimetry and predictive factors.

Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models

Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate Cancer

Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy?

Does prostate volume has an impact on biochemical failure in patients with localized prostate cancer treated with HDR boost?

Dose escalation to the dominant intraprostatic lesion defined by sextant biopsy in a permanent prostate I-125 implant: a prospective comparative toxicity analysis.

Dosimetric consequences of manual pullback procedure for coronary artery radiotherapy with 90Sr/90Y beta-source

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial

External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer

High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomes

Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy.

Image-guided high-dose-rate brachytherapy boost to the dominant intraprostatic lesion using multiparametric magnetic resonance imaging including spectroscopy: Results of a prospective study.

Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy

Multicenter Evaluation of Biochemical Relapse-Free Survival Outcomes for Intraoperatively Planned Prostate Brachytherapy Using an Automated Delivery System.

Permanent prostate implant using high activity seeds and inverse planning with fast simulated annealing algorithm: A 12-year Canadian experience.

Postimplant dosimetry using a Monte Carlo dose calculation engine: a new clinical standard

Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.

RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients.

Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer

Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data.

The Prostate Cancer Risk Stratification Project: Database Construction and Risk Stratification Outcome Analysis

The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysis.

Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian population.

[Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience]

[The impact of 3D image guided prostate brachytherapy on therapeutic ratio: the Quebec University Hospital experience]